| RNA interference |
11.0% |
| stem cell proliferation |
10.1% |
| gene silencing |
12.1% |
| innate immune response |
13.0% |
| segmentation |
10.1% |
| inflammatory cell apoptosis |
10.3% |
| neurogenesis |
12.3% |
| neuroprotection |
11.2% |
| mesenchymal cell development |
10.2% |
| protein ubiquitination |
13.2% |
| autophagy |
22.5% |
| histone acetylation |
10.7% |
| mesenchymal cell proliferation |
14.2% |
| histone methylation |
14.1% |
| stem cell maintenance |
13.0% |
| adaptive immune response |
14.1% |
| chromatin remodeling |
11.6% |
| chromatin silencing |
10.8% |
| histone modification |
13.2% |
| microglial cell activation |
10.8% |
| chromatin modification |
11.4% |
| triglyceride homeostasis |
10.7% |
| histone lysine methylation |
13.7% |
| DNA demethylation |
11.6% |
| transdifferentiation |
10.4% |
| Notch signaling pathway |
14.2% |
| histone H3 acetylation |
11.8% |
| cell redox homeostasis |
10.4% |
| chromatin maintenance |
12.3% |
| Toll signaling pathway |
13.5% |
| chromatin assembly or disassembly |
11.6% |
| mesenchymal cell apoptosis |
15.4% |
| toll-like receptor signaling pathway |
13.7% |
| endoplasmic reticulum unfolded protein response |
17.0% |
| nucleosome assembly |
10.4% |
| post-translational protein acetylation |
11.0% |
| lymphangiogenesis |
13.8% |
| protein sumoylation |
13.4% |
| autophagic cell death |
16.5% |
| vascular endothelial growth factor receptor signaling pathway |
11.0% |
| BMP signaling pathway |
12.0% |
| toll-like receptor 1 signaling pathway |
13.4% |
| store-operated calcium entry |
10.0% |
| sprouting angiogenesis |
12.8% |
| Wnt receptor signaling pathway |
14.6% |
| toll-like receptor 4 signaling pathway |
13.9% |
| pre-miRNA processing |
20.1% |
| toll-like receptor 2 signaling pathway |
13.2% |
| anti-apoptosis |
11.8% |
| catabolic process |
10.7% |
| mitochondrial fission |
15.8% |
| kinetochore assembly |
12.6% |
| toll-like receptor 3 signaling pathway |
13.1% |
| anoikis |
12.8% |
| neural precursor cell proliferation |
10.5% |
| cell fate commitment |
11.1% |
| nucleosome positioning |
10.5% |
| protein polyubiquitination |
13.7% |
| peroxisome proliferator activated receptor signaling pathway |
10.9% |
| androgen receptor signaling pathway |
11.8% |
| nucleosome disassembly |
13.5% |
| protein catabolic process |
10.3% |
| macroautophagy |
17.7% |
| histone ubiquitination |
17.9% |
| myeloid cell homeostasis |
13.7% |
| nitric oxide storage |
10.8% |
| heterochromatin assembly |
11.3% |
| tendon cell differentiation |
10.4% |
| germ-line stem cell maintenance |
14.4% |
| T-helper 17 cell differentiation |
20.2% |
| cilium assembly |
12.7% |
| progesterone receptor signaling pathway |
11.2% |
| protein glutathionylation |
16.6% |
| toll-like receptor 7 signaling pathway |
13.1% |
| protein monoubiquitination |
16.3% |
| protein lipidation |
12.0% |
| chronological cell aging |
11.8% |
| toll-like receptor 9 signaling pathway |
12.8% |
| smoothened signaling pathway |
15.8% |
| somatic stem cell maintenance |
17.6% |
| virus-host interaction |
11.5% |
| neuronal stem cell maintenance |
11.7% |
| canonical Wnt receptor signaling pathway |
17.0% |
| protein deubiquitination |
11.6% |
| reactive oxygen species metabolic process |
10.9% |
| neuroblast proliferation |
12.3% |
| protein lipoylation |
15.2% |
| kinetochore organization |
10.3% |
| natural killer cell degranulation |
16.3% |
| mitochondrial respiratory chain complex assembly |
11.5% |
| response to endoplasmic reticulum stress |
13.7% |
| dendritic spine morphogenesis |
15.8% |
| primary miRNA processing |
21.1% |
| superior temporal gyrus development |
16.4% |
| glycerol metabolic process |
11.2% |
| microtubule severing |
11.8% |
| oncogene-induced senescence |
22.9% |
| MyD88-dependent toll-like receptor signaling pathway |
13.5% |
| stress-induced premature senescence |
10.0% |
| extracellular matrix disassembly |
11.5% |
| organic acid metabolic process |
11.0% |
| cellular response to cold |
10.4% |
| histone H2A ubiquitination |
14.6% |
| histone H2B ubiquitination |
15.3% |
| protein neddylation |
15.9% |
| response to unfolded protein |
14.5% |
| succinate metabolic process |
11.3% |
| ribosomal small subunit biogenesis |
10.9% |
| ephrin receptor signaling pathway |
11.3% |
| cell-cell junction organization |
11.0% |
| synaptic vesicle clustering |
10.2% |
| flavonoid metabolic process |
10.2% |
| multivesicular body sorting pathway |
12.8% |
| axon cargo transport |
10.5% |
| neural crest cell fate specification |
12.8% |
| MyD88-independent toll-like receptor signaling pathway |
11.0% |
| stress granule assembly |
21.7% |
| protein K63-linked ubiquitination |
21.0% |
| posterior head segmentation |
11.5% |
| common myeloid progenitor cell proliferation |
10.7% |
| protein autoubiquitination |
13.9% |
| T-helper cell lineage commitment |
13.4% |
| heme export |
10.3% |
| oxidative DNA demethylation |
15.2% |
| interkinetic nuclear migration |
13.0% |
| DNA catabolic process |
10.0% |
| oxidative stress-induced premature senescence |
11.2% |
| histone monoubiquitination |
26.7% |
| base-excision repair, DNA ligation |
13.1% |
| peroxisome fission |
17.1% |
| Golgi ribbon formation |
13.4% |
| RNA catabolic process |
12.2% |
| protein desumoylation |
12.5% |
| response to misfolded protein |
21.1% |
| epithelial to mesenchymal transition |
24.3% |
| mesenchymal to epithelial transition |
24.3% |
| intein-mediated protein splicing |
11.0% |
| zinc ion transmembrane transport |
11.0% |
| anatomical structure regression |
12.5% |
| cellular response to misfolded protein |
19.7% |
| protein deglutathionylation |
18.3% |
| medium-chain fatty acid biosynthetic process |
14.3% |
| G2/M transition DNA damage checkpoint |
11.4% |
| protein targeting to plasma membrane |
11.4% |
| urate metabolic process |
13.0% |
| heme metabolic process |
10.3% |
| telomere maintenance via telomerase |
11.9% |
| proteasome regulatory particle assembly |
22.7% |
| signalosome assembly |
10.6% |
| collagen catabolic process |
16.1% |
| embryonic pectoral fin morphogenesis |
11.5% |
| mRNA catabolic process |
13.6% |
| T-helper 1 cell lineage commitment |
15.8% |
| hepatoblast differentiation |
12.5% |
| glial cell fate commitment |
10.7% |
| cullin deneddylation |
10.9% |
| proepicardium development |
16.7% |
| mitochondrial respiratory chain complex II assembly |
16.7% |
| neuromast development |
11.3% |
| valine metabolic process |
13.5% |
| formate metabolic process |
11.5% |
| Wnt receptor signaling pathway, planar cell polarity pathway |
20.0% |
| age-dependent telomere shortening |
16.0% |
| sinoatrial node cell differentiation |
14.0% |
| histone deubiquitination |
12.0% |
| double-strand break repair via nonhomologous end joining |
10.0% |
| replication fork protection |
24.5% |
| Roundabout signaling pathway |
14.3% |
| vitamin K metabolic process |
12.2% |
| butyrate metabolic process |
12.2% |
| protein homooligomerization |
10.2% |
| septin ring assembly |
14.6% |
| cytosol to ER transport |
10.4% |
| hippo signaling cascade |
36.2% |
| membrane to membrane docking |
12.8% |
| piRNA metabolic process |
13.0% |
| polyphosphate metabolic process |
10.9% |
| non-canonical Wnt receptor signaling pathway |
27.3% |
| CD24 biosynthetic process |
15.9% |
| mitochondrial protein catabolic process |
15.9% |
| ATP catabolic process |
11.4% |
| fumarate metabolic process |
11.4% |
| central nervous system vasculogenesis |
11.6% |
| protein K48-linked ubiquitination |
14.3% |
| short-chain fatty acid metabolic process |
22.0% |
| L-serine catabolic process |
19.5% |
| cell surface pattern recognition receptor signaling pathway |
10.0% |
| thermosensory behavior |
15.4% |
| sister chromatid biorientation |
21.1% |
| protein targeting to lysosome |
10.5% |
| oxaloacetate metabolic process |
10.8% |
| multicellular organismal development |
19.4% |
| T-tubule organization |
17.1% |
| protein localization to synapse |
11.8% |
| leptin-mediated signaling pathway |
12.1% |
| telomere maintenance via recombination |
12.5% |
| circadian sleep/wake cycle, REM sleep |
12.5% |
| helper T cell extravasation |
12.5% |
| stress granule disassembly |
16.7% |
| corticospinal tract morphogenesis |
13.3% |
| nucleotide-excision repair, DNA gap filling |
10.0% |
| syncytial blastoderm mitotic cell cycle |
10.0% |
| copper ion import |
10.0% |
| endoplasmic reticulum tubular network organization |
13.8% |
| histone H4-K16 acetylation |
13.8% |
| isoleucine metabolic process |
17.9% |
| cytoplasmic mRNA processing body assembly |
18.5% |
| histone H2A monoubiquitination |
19.2% |
| myelination in peripheral nervous system |
19.2% |
| low-density lipoprotein particle remodeling |
11.5% |
| T-helper 17 cell chemotaxis |
20.0% |
| astrocyte fate commitment |
16.0% |
| plasma membrane to endosome transport |
12.0% |
| dendrite self-avoidance |
34.8% |
| retrograde axon cargo transport |
17.4% |
| telomere maintenance via telomere shortening |
13.6% |
| UDP-glucose metabolic process |
20.0% |
| retrograde transport, endosome to Golgi |
10.0% |
| transposition, DNA-mediated |
10.0% |
| endosomal lumen acidification |
21.1% |
| PML body organization |
10.5% |
| cloacal septation |
10.5% |
| glutamine catabolic process |
10.5% |
| one-carbon metabolic process |
22.2% |
| interleukin-6-mediated signaling pathway |
22.2% |
| histone H3-S10 phosphorylation |
22.2% |
| phytol metabolic process |
11.1% |
| pyridoxal 5-phosphate salvage |
11.1% |
| tumor necrosis factor-mediated signaling pathway |
17.6% |
| receptor localization to synapse |
11.8% |
| glycolate metabolic process |
11.8% |
| cellular response to glucose starvation |
12.5% |
| estrogen catabolic process |
12.5% |
| lysosomal lumen acidification |
26.7% |
| heparan sulfate proteoglycan metabolic process |
13.3% |
| histone H4-K5 acetylation |
13.3% |
| oligodendrocyte cell fate commitment |
13.3% |
| lipopolysaccharide-mediated signaling pathway |
28.6% |
| sphingolipid catabolic process |
21.4% |
| branchiomeric skeletal muscle development |
14.3% |
| cellular response to insulin stimulus |
14.3% |
| aggresome assembly |
14.3% |
| nucleotide-excision repair, DNA duplex unwinding |
14.3% |
| ferrous iron import |
30.8% |
| M phase specific microtubule process |
15.4% |
| fructose catabolic process |
16.7% |
| ruffle assembly |
16.7% |
| lymphocyte chemotaxis across high endothelial venule |
16.7% |
| glycosphingolipid catabolic process |
16.7% |
| iridophore differentiation |
18.2% |
| early endosome to late endosome transport |
18.2% |
| multicellular organismal aging |
50.0% |
| lysine catabolic process |
40.0% |
| glucosamine catabolic process |
30.0% |
| nucleotide-binding oligomerization domain containing signaling pathway |
20.0% |
| water-soluble vitamin metabolic process |
10.0% |
| protein folding in endoplasmic reticulum |
10.0% |
| succinyl-CoA metabolic process |
10.0% |
| phytoalexin metabolic process |
10.0% |
| protein localization in mitochondrion |
10.0% |
| nitric oxide production involved in inflammatory response |
10.0% |
| response to UV-C |
11.1% |
| nucleotide-excision repair, DNA incision, 3-to lesion |
11.1% |
| ventral spinal cord interneuron fate determination |
11.1% |
| exogenous drug catabolic process |
11.1% |
| protein heterotetramerization |
11.1% |
| very-low-density lipoprotein particle remodeling |
11.1% |
| embryonic process involved in female pregnancy |
11.1% |
| oenocyte development |
11.1% |
| protein K11-linked ubiquitination |
50.0% |
| protein linear polyubiquitination |
37.5% |
| paranodal junction assembly |
12.5% |
| alternative nuclear mRNA splicing, via spliceosome |
12.5% |
| glycerol ether metabolic process |
12.5% |
| low-density lipoprotein particle mediated signaling |
12.5% |
| adiponectin-mediated signaling pathway |
12.5% |
| eye pigment granule organization |
12.5% |
| posterior lateral line neuromast primordium migration |
12.5% |
| COPII vesicle coating |
42.9% |
| nucleotide-binding oligomerization domain containing 2 signaling pathway |
28.6% |
| intermediate filament bundle assembly |
28.6% |
| glucose 1-phosphate metabolic process |
14.3% |
| deoxyribonucleoside catabolic process |
14.3% |
| branched chain family amino acid biosynthetic process |
14.3% |
| de novo cotranslational protein folding |
14.3% |
| inositol phosphate-mediated signaling |
14.3% |
| immunoglobulin production in mucosal tissue |
14.3% |
| histone mRNA metabolic process |
50.0% |
| age-dependent response to reactive oxygen species |
33.3% |
| defense response to nematode |
33.3% |
| leukocyte migration involved in immune response |
16.7% |
| polar body extrusion after meiotic divisions |
16.7% |
| mitochondrial fragmentation involved in apoptosis |
16.7% |
| dermatan sulfate proteoglycan metabolic process |
16.7% |
| Wnt receptor signaling pathway, calcium modulating pathway |
60.0% |
| plus-end-directed vesicle transport along microtubule |
40.0% |
| embryonic olfactory bulb interneuron precursor migration |
20.0% |
| diacylglycerol catabolic process |
20.0% |
| cysteine biosynthetic process via cystathionine |
20.0% |
| nucleoside triphosphate catabolic process |
20.0% |
| semaphorin-plexin signaling pathway |
20.0% |
| keratan sulfate metabolic process |
20.0% |
| nucleotide-sugar metabolic process |
50.0% |
| flavone metabolic process |
50.0% |
| I-kappaB kinase/NF-kappaB cascade |
25.0% |
| phosphatidylinositol-mediated signaling |
25.0% |
| response to organic cyclic compound |
25.0% |
| 3-UTR-mediated mRNA stabilization |
25.0% |
| barrier septum assembly |
25.0% |
| cell-substrate junction assembly |
25.0% |
| anthranilate metabolic process |
25.0% |
| RNA splicing, via transesterification reactions |
25.0% |
